Comparison of the Effectiveness of Local Ozone Injection and Dextrose Prolotherapy Injection in Chronic Plantar Fasciitis

Inclusion Criteria: * 18-75 years old, both sexes * Pain in the plantar medial calcaneal tubercle on palpation for more than 3 months * Accepting to participate in the study * Heel pain, especially in the first few steps in the morning, increasing with loading during the day * Patients with an initial VAS assessment of 4 or more on a 10 cm scale Exclusion Criteria: * Hyperthyroidism * Glucose6 phosphate dehydrogenase deficiency * Ozone allergy * Acute metabolic disease comorbidity (acute MI, acute hyperglycaemia, diabetic ketoacidosis, acute cerebrovascular disease etc.) * Pregnancy and breastfeeding * Malignite * Epilepsy * Tipl, having a history of type 2 diabetes * History of inflammatory rheumatic disease * History of bleeding disorders * Use of anticoagulants other than aspirin * Local corticosteroid injection into the plantar fascia within the last 3 months to have a story * ESWT treatment of the plantar fascia in the last 3 months * To have received physiotherapy to the foot, ankle area within the last 3 months * History of foot and ankle surgery * Active infection at the application site (cellulitis, erysipelas, etc.) * Allergy to dextrose * History of peripheral neuropathy * SI radiculopathy